How Will the Market React to Savara Inc (SVRA) Stock Getting a Bullish Rating

Overall market sentiment has been high on Savara Inc (SVRA) stock lately. SVRA receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Savara Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SVRA!

See Full SVRA Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With SVRA Stock Today?

Savara Inc (SVRA) stock has gained 1.12% while the S&P 500 is down -0.2% as of 9:53 AM on Tuesday, Aug 1. SVRA is up $0.04 from the previous closing price of $3.58 on volume of 305,529 shares. Over the past year the S&P 500 has risen 11.20% while SVRA is up 115.48%. SVRA lost -$0.26 per share in the over the last 12 months. To screen for more stocks like Savara Inc click here.

More About Savara Inc

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Click Here to get the full Stock Report for Savara Inc stock.